expression of Sarcoplasmic Reticulum Calcium-transporting ATPase (SERCA2a) decrease in diabetes, leading to diastolic and systolic dysfunction of myocardium. It was recently reported that SUMOylation could elevate the activity and stability of SERCA2a. We assume that diabetes might affect the intensity of SUMOylation of SERCA2a after MI.
CONCLUSIONS SUMOylation intensity of SERCA2a was compensatory enhanced in post-MI non-diabetic rats, but not in diabetic rats. SUMOylation intensity of SERCA2a decreased in cardiomyocytes with addition of high glucose and insulin in vitro, which could be neutralized by overexpression of Ubc9. These observations provide evidence that Ubc9 and SUMOylation of SERCA2a is involved in diabetes-mediated exacerbation of left ventricular dysfunction after MI.
GW26-e3918 DCPIB Attenuates Myocardial Ischemia/Reperfusion Injury Through Inhibiting Autophagy in Rat Model
Yuesheng Xia, Lin Wang, Rong Xu, Yuan Xiao, Xiaoming Wang Department of Geriatrics, Xijing Hospital, Fourth Military Medical University OBJECTIVES Autophagy plays a contradictory role in myocardial ischemia/reperfusion (I/R) process, which acts as both beneficial cardioprotective during ischemia stress and myocardial injury in response to subsequent reperfusion. DCPIB (4-[(2-Butyl-6,7dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy] butanoic acid), a selective inhibitor of volume-sensitive outwardly rectifying (VSOR) chlorine channel, has been determined to protect cardiomyocytes from reperfusion damage. However, the underlying mechanism remains unclear. The present study explored the possible mechanism of DCPIB in alleviating myocardial I/R injury.
METHODS Sprague-Dawley rats were randomly divided into sham operation group, I/R group, I/R+Rapamycin (RAPA) group, I/R+DCPIB group, I/R+3-methyladenine (3MA, a autophagic inhibitor) group and I/R+RAPA+DCPIB group, with 6 rats in each group. Rats were performed to ischemia 30 minutes and subsequent reperfusion 24 hours, DCPIB (10mg/kg), RAPA(4mg/kg) and 3MA (1mg/kg) were administered as intraperitoneal injection 10 min before the onset of reperfusion, respectively. Serum myocardial enzymes were measured and light microscopic study was performed, the myocardial LC3 was detected by immunohistochemistry, nuclear factor-kB (NF-kB) and tumor necrosis factor a (TNF-a) were detected by enzyme-linked immunosorbent assay (ELISA).
RESULTS
The expressions of myocardial LC3, TNFa and NF-kB were significantly increased (P<0.05), and cardiac function was declined in I/R group compared with that in sham operation group (P<0.05), myocardial LC3 were furthermore increased in RAPA group, whereas these could be reversed through 3MA, a autophagic inhibitor. Of note, DCPIB administration caused significant reduction of myocardial LC3, TNF-a and NF-kB (P<0.05), and significantly improved the cardiac functional recovery and reduced myocardial enzymes activity compared with that in I/R group and I/R+RAPA+DCPIB group (P<0.05). Specific details for hemodynamics, compared to sham-operated group, left ventricular systolic pressure (LVSP), maximal rate of increase of ventricular pressure (+dp/dt max ) and maximal rate of decrease of ventricular pressure (-dp/dt max ) decreased while left ventricular end diastolic pressure (LVEDP) significantly increased markedly in I/R group and I/R+RAPA group (P<0.05), however, DCPIB indeed reversed the disorder.
CONCLUSIONS Our results demonstrated that DCPIB attenuated excessive autophagy to protect rat heart from I/R injury.
GW26-e3941
Urokinase Receptor Accelerates Ox-LDL Uptake and Foam Cell Formation by Upregulating CD36 Expression on Macrophages Yan Zhang, Wei Chen, Quan Fang Peking Union Medical College Hospital OBJECTIVES To investigate the role of uPAR in ox-LDL uptake and the interaction of uPAR and CD36 in ox-LDL internalization by macrophages.
METHODS THP-1 cells transfected with uPAR complementary DNA (uPAR overexpression THP-1, UOT) or with uPAR shRNA (uPAR lowexpression THP-1, ULT) were established. Laser Scanning Confocal Microscope and dil-ox-LDL were used to evaluate ox-LDL uptake capacities. Oil red O staining was performed to measure lipid accumulation and foam cell formation. Cytokine expression levels of cytokines were quantitated by Real-Time-PCR.
RESULTS Ox-LDL-induced uPAR expression was independent of its baseline expression level in macrophages. UOT cells showed a strong correlation of uPAR expression with ox-LDL uptake. Much earlier dilox-LDL internalization and significantly more lipid droplets were found in UOT cells. Stable expression of a shRNA targeting uPAR gene strongly inhibits lipid uptake by macrophages. UOT cells exhibited significantly higher transcriptional levels of CD36 mRNA upon stimulation of ox-LDL.
CONCLUSIONS uPAR accelerates ox-LDL uptake and foam cell formation in macrophages, which may be mediated by CD36 upregulation. The interaction between uPAR and CD36 may be a potential new therapeutic target.
GW26-e3962 Activation of D4 Dopamine Receptor Decreases AT1 Angiotensin II Receptor Expression in Rat Renal Proximal Tubule Cells
Chen Ken, 1,2 Zeng Chunyu 1,2 1 Department of Cardiology, Hospital of Cardiology in Daping Hospital, The Third Military Medical University; 2 Chongqing Institute of Cardiology, Chongqing, P.R.China OBJECTIVES The dopaminergic and renin angiotensin systems interact to regulate blood pressure. Disruption of the D 4 dopamine receptor gene in mice produces hypertension that is associated with increased renal AT 1 receptor expression. We hypothesize that D 4 receptor can inhibit AT 1 receptor expression and function in renal proximal tubules (RPTs) cells from Wistar-Kyoto (WKY) rats, the regulation of D 4 receptor on AT 1 receptor is aberrant in RPT cells from spontaneously hypertensive rats (SHRs).
METHODS
The AT 1 receptor protein expression is detected by immunoblotting. Na + -K + -ATPase activity was determined as the rate of inorganic phosphate released in the presence or absence of ouabain.
RESULTS The D 4 receptor agonist, PD168077, decreased AT 1 receptor protein expression in a time (0-30hrs)-and concentration (10 -9 -10 -5 M)dependent manner in WKY RPT cells. In contrast, in SHR cells, PD168077 (10 -6 M) increased AT 1 receptor protein expression. The inhibitory effect of D 4 receptor on AT 1 receptor expression in WKY RPT cells was blocked by a calcium channel blocker, nicardipine (10 -6 M) or calcium free medium, indicating that calcium channel was involved as a signaling molecule in the D 4 receptor-mediated signaling pathway. Angiotensin II (10 -11 M) increased Na + -K + ATPase activity in WKY cells. Pretreatment with PD168077 (10 -6 M/24hrs) decreased the stimulatory effects of angiotensin II on Na + -K + ATPase activity in WKY cells. However, in SHR cells, the inhibitory effect of D 4 receptor on angiotensin II-mediated effect on Na + -K + ATPase activity was aberrant; pretreatment with D 4 receptor agonist augmented the stimulatory effect of AT 1 receptor on Na + -K + ATPase activity in SHR cells.
CONCLUSIONS We suggest that a differential interaction between D 4 and AT 1 receptors may play a role in the differential regulation of sodium excretion and blood pressure in hypertension.
GW26-e4459
Cellular Electrophysiological Mechanisms and Drug Intervention Study of the CACNA1C Gene Mutation Related to Early Repolarization Xin Liu, 1 Yang Shen, 1 Qing Cao, 2 Jinyan Xie, 2 Ping Yuan, 1 Wei Lai, 1 Xiaogang Peng, 2 Rong Wan, 2 Kui Hong 1,2 1 Department of Cardiology, the Second Affiliated Hospital of Nanchang University; 2 The Key Laboratory of Molecular Medicine, the Second Affiliated Hospital of Nanchang University OBJECTIVES To investigate the electrophysiological mechanisms of mutated cardiac L-type calcium channel (LTCC) caused by a CACNA1C gene mutation in ER from cellular level, and screening of effective drug treatment.
METHODS Patients with early repolarization syndrome (ERS) were recruited according to the 2013 HRS/EHRA/APHRS diagnostic expert consensus statement. Mutation analysis was detected by direct sequencing. HEK293 cells were co-transfected with wild type or mutant human CACNA1C, and its auxiliary unit contained CACNB2b and CACNA2D1 for the cellular electrophysiological and drug intervention study of LTCC.
RESULTS A missense mutation in CACNA1C gene (c.5747A > G, p.Q1916R) was identified in a 34-year-old male patient. The mutant Ltype calcium current (I Ca-L ) in HEK293 cells declined when compared to the wild calcium channel, (P ＜0.05, P ＜0.01), there is no difference of the voltage dependent SSA between the 2 groups. The testosterone (10 mM) significantly reduces the current density (P ＜0.05). The therapeutic drug for ERS of isoproterenol (10 mM) increases the wild calcium current density, while the increased mutant calcium current density without statistical significance. The quinidine (5 mM) has no any effect on the calcium current density and voltage dependent SSA in the both groups.
CONCLUSIONS In conclusion, a novel CACNA1C mutation might be associated with the ERS. The CACNA1C-Q1916R is a loss-of-function mutation with decreased calcium current. The testosterone exacerbates the decreased CACNA1C-Q1916R mutant calcium current density, which suggests that the male gender is an important risk factor ERS. There might be no therapeutic effect of isoproterenol in the CACNA1C-Q1916R mutant carrier related to the early repolarization we studied here.
GW26-e4460

Up-Regulation of Neuronal Nitric Oxide Synthase Modulates Myofilament Ca2+ Sensitivity and Controls Left Ventricular Myocyte Contractility in Hypertensive Rats
Lan Cui, Chunzi Jin Yan Bian University Hospital
OBJECTIVES Hypertension is one of the major risk factors for developing cardiac hypertrophy and heart failure. Although cellular signaling pathways, intracellular Ca 2+ handling and myofilament Ca 2+ sensitivity are known to be altered in hypertensive myocardium, mechanisms mediating left ventricular (LV) contractile function remain to be defined. It is known that neuronal nitric oxide synthase (nNOS) is up-regulated in hypertensive myocardium, however, its role in myocyte Ca 2+ handling and myofilament Ca 2+ sensitivity and their interplays in regulating contractile function is not clear. Therefore, we aim to test the functional regulation by nNOS of LV myocyte contraction in angiotensin II (Ang II)-induced hypertensive rats.
METHODS Sprague-Dawley rats (8 weeks old, male) were subjected to Ang II infusion subcutaneously using osmotic minipump for 4 weeks (125ng/min/kg). These animals were paired with sham-operated groups. LV myocytes were isolated using a standard enzymatic dispersion technique. Contraction and relaxation were measured in LV myocytes (field-stimulation at 2 Hz, 36AE1oC) by using a videosarcomere detection system (IonOptix Corp).
RESULTS Systemic blood pressure was elevated in Ang II-treated rats (osmotic minipump, 4 weeks) compared to that in shams. Functional analysis showed that LV myocyte sarcomere shortening was unchanged and relaxation was faster in Ang II-rats compared to those from shams. L-type Ca 2+ channel activity (ICa) was not different between two groups, however, peak [Ca 2+ ]i was increased (Fura 2, F360/F380) and decay of [Ca 2+ ]i (tau) was faster in Ang IIrats. These changes were accompanied by reduced myofilament Ca 2+ sensitivity (EC50). Immunoblotting results revealed that nNOS protein expression was significantly increased (optical density of nNOS/GAPDH) in LV myocyte homogenates from Ang II-rats. Inhibition of nNOS with specific inhibitors, S-methyl-L-thiocitrulline (SMTC, 100 nM) or N5-(1-Imino-3-butenyl)-L-ornithine (L-VNIO, 100 uM) restored myofilament Ca 2+ sensitivity and reduced [Ca 2+ ]i in Ang II-rats. As a result, LV myocyte contraction was maintained unaltered. Interestingly, ICa was increased by nNOS inhibition (similar to that in sham) but tau of [Ca 2+ ]i was not affected, despite that relaxation was significantly prolonged by SMTC or L-VNIO in Ang II-rats. A specific inhibitor of protein kinase G (KT 5823, 1 uM) mimicked the effect of nNOS and increased myofilament Ca 2+ sensitivity, [Ca 2+ ]i and LV myocyte contraction.
CONCLUSIONS These results suggest that reduced myofilament Ca 2+ sensitivity by nNOS plays predominant role in controlling intracellular Ca 2+ handling and LV myocyte contractility in hypertension.
GW26-e4492
Inhibition of VDAC1 Prevents Ca2+-Mediated Oxidative Stress and Apoptosis Induced by 5-Aminolevulinic Acid Mediated Sonodynamic Therapy in THP-1 Macrophages Weiwei Gao, 1,2 Haibo Chen, 1,2 Ye Tian 1,2 1 Department of Cardiology, The First Affiliated Hospital, Cardiovascular Institute, Harbin Medical University; 2 Department of Pathophysiology, Key Laboratory of Cardiovascular Pathophysiology, Harbin Medical University OBJECTIVES Ultrasound combined with endogenous protoporphyrin IX derived from 5-aminolevulinic acid (ALA-SDT) is known to induce apoptosis in multiple cancer cells and macrophages. Persistent retention of macrophages in the plaque has been implicated in the pathophysiology and progression of atherosclerosis. Here we investigated the effects of inhibition of voltage-dependent anion channel 1 (VDAC1) on ALA-SDT-induced THP-1 macrophages apoptosis.
METHODS Cells were pre-treated with VDAC1 inhibitor 4, 4' -diisothiocyanostilbene-2, 2' -disulfonic acid (DIDS) disodium salt for 1 h or downregulated VDAC1 expression by small interfering RNA and exposed to ultrasound. Cell viability was assessed by MTT assay, and cell apoptosis along with necrosis was evaluated by Hoechst 33342/ propidium iodide staining and flow cytometry. Levels of cytochrome c release was assessed by confocal microscope and Western blot. The levels of full length caspases, caspase activation, and VDAC isoforms were analyzed by Western blot. Intracellular reactive oxygen species generation, mitochondrial membrane permeability, and intracellular Ca 2+ ([Ca 2+ ] i ) levels were measured with fluorescent probes.
RESULTS
The pharmacological inhibition of VDAC1 by DIDS notably prevented ALA-SDT-induced cell apoptosis in THP-1 macrophages. DIDS significantly inhibited intracellular ROS generation and apoptotic biochemical changes such as inner mitochondrial membrane permeabilization, loss of mitochondrial membrane potential, cytochrome c release and activation of caspase-3 and caspase-9. Moreover, ALA-SDT elevated the [Ca 2+ ] i levels and it was also notably reduced by DIDS. Furthermore, both of intracellular ROS generation and cell apoptosis were predominately inhibited by Ca 2+ chelating reagent BAPTA-AM. Intriguingly, ALA-treatment markedly augmented VDAC1 protein levels exclusively, and the downregulation of VDAC1 expression by specific siRNA also significantly abolished cell apoptosis.
CONCLUSIONS VDAC1 plays a crucial role in ALA-SDT-induced THP-1 macrophages apoptosis, and targeting VDAC1 is a potential way regulating macrophages apoptosis. This finding may be relevant to therapeutic strategies against atherosclerosis. 
